BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20184100)

  • 1. Types and frequencies of hemoglobin disorders in the pacific coast of four states of Mexico.
    Cobián JG; Sánchez-López JY; Magaña MT; Chávez ML; Perea FJ; Ibarra B
    Rev Invest Clin; 2009; 61(5):399-404. PubMed ID: 20184100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Abnormal hemoglobins and thalassemias in Mexico].
    Ruiz-Reyes G
    Rev Invest Clin; 1998; 50(2):163-70. PubMed ID: 9658939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical and laboratory spectrum of Hb C [β6(A3)Glu→Lys, GAG>AAG] disease.
    Cook CM; Smeltzer MP; Mortier NA; Kirk SE; Despotovic JM; Ware RE; Hankins JS
    Hemoglobin; 2013; 37(1):16-25. PubMed ID: 23297836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular spectrum of beta-thalassemia in the Mexican population.
    Perea FJ; Magaña MT; Cobián JG; Sánchez-López JY; Chávez ML; Zamudio G; Esparza MA; López-Guido B; Ibarra B
    Blood Cells Mol Dis; 2004; 33(2):150-2. PubMed ID: 15315794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalassemias and other hemoglobinopathies in the Republic of Macedonia.
    Efremov GD
    Hemoglobin; 2007; 31(1):1-15. PubMed ID: 17365000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular lesion frequency of hemoglobin gene disorders in Taiwan.
    Liu SC; Peng CT; Lin TH; Wang SJ; Shih MC; Tien N; Chang CC; Lu JJ; Lin CY
    Hemoglobin; 2011; 35(3):228-36. PubMed ID: 21599435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of hemoglobin disorders and glucose-6-phosphate dehydrogenase (G6PD) deficiency in the Republic of Guinea (West Africa).
    Millimono TS; Loua KM; Rath SL; Relvas L; Bento C; Diakite M; Jarvis M; Daries N; Ribeiro LM; Manco L; Kaeda JS
    Hemoglobin; 2012; 36(1):25-37. PubMed ID: 21929367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HB Fannin-Lubbock-I with a single GGC>GAC mutation at beta119(GH2)Gly-->Asp in a homozygous Mexican patient.
    Ibarra B; Aizpuru E; Sánchez-López JY; Morales KR; Perea FJ; Ruiz-Reyes G
    Hemoglobin; 2009; 33(6):492-7. PubMed ID: 19958195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micromapping of thalassemia and hemoglobinopathies in diferent regions of northeast Thailand and Vientiane, Laos People's Democratic Republic.
    Tritipsombut J; Sanchaisuriya K; Phollarp P; Bouakhasith D; Sanchaisuriya P; Fucharoen G; Fucharoen S; Schelp FP
    Hemoglobin; 2012; 36(1):47-56. PubMed ID: 22122810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalassemia and hemoglobinopathies in Thua Thien Hue Province, Central Vietnam.
    Nguyen HV; Sanchaisuriya K; Nguyen D; Phan HT; Siridamrongvattana S; Sanchaisuriya P; Fucharoen S; Fucharoen G; Schelp FP
    Hemoglobin; 2013; 37(4):333-42. PubMed ID: 23600535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data].
    Fattoum S
    Tunis Med; 2006 Nov; 84(11):687-96. PubMed ID: 17294892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemoglobin variants in Colombian patients referred to discard hemoglobinopathies].
    Romero-Sánchez C; Gómez Gutiérrez A; Duarte Y; Amazo C; Manosalva C; Chila M L; Casas-Gómez MC; Briceño Balcázar I
    Rev Med Chil; 2015 Oct; 143(10):1260-8. PubMed ID: 26633269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of hemoglobin alterations in a sample population in northwest Mexico. Preliminary report.
    Ibarra B; Zúñiga P; Ramírez ML; Martínez-Orozco LC; Cantú JM
    Arch Invest Med (Mex); 1980; 11(4):491-6. PubMed ID: 7212909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advantages in the use of high performance liquid chromatography technique for screening hemoglobinopathies in Venezuela].
    Bravo-Urquiola M; Arends A; Montilla S; Velásquez D; Garcìa G; Alvarez M; Guevara J; Castillo O
    Invest Clin; 2004 Dec; 45(4):309-15. PubMed ID: 15602897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular-genetic characteristics of alpha, beta and delta beta-thalassemias in 139 heterozygotes in 56 unrelated Czech and Slovak families (Priority description of 3 beta-thalassemia mutations, an extensive alpha-thalassemia 2 (18+ kb) deletion and a Swiss-type nondeletion hereditary persistence of hemoglobin F)].
    Indrák K; Divoký V; Brabec V; Indráková J; Svobodová M; Huisman TH
    Vnitr Lek; 1993 Oct; 39(10):969-78. PubMed ID: 7694425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal hemoglobins in Northwestern Mexico.
    Ibarra B; Vaca G; Franco-Gamboa E; Garcia-Cruz D; de la Mora E; Castro-Felix LP; Martinez-Orozco LC; Cantu JM; Wilson JB; Lam H
    Acta Anthropogenet; 1982; 6(4):217-23. PubMed ID: 7187237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of beta-thalassemia and other hemoglobinopathies in Bulgaria: an update.
    Petkov GH; Efremov GD
    Hemoglobin; 2007; 31(2):225-32. PubMed ID: 17486505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of β-thalassemia in the United Arab Emirates.
    Baysal E
    Hemoglobin; 2011; 35(5-6):581-8. PubMed ID: 22074124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis and hematologic characterization of deltabeta-thalassemia and hereditary persistence of fetal hemoglobin in Thailand.
    Panyasai S; Fucharoen S; Surapot S; Fucharoen G; Sanchaisuriya K
    Haematologica; 2004 Jul; 89(7):777-81. PubMed ID: 15257928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn screening for hemoglobin disorders.
    Hoppe CC
    Hemoglobin; 2011; 35(5-6):556-64. PubMed ID: 21910601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.